Comparison Between Sitagliptin Add-on Therapy and Insulin Dose Increase Therapy for Uncontrolled Type 2 Diabetes on Insulin Therapy.
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2013
At a glance
- Drugs Sitagliptin (Primary) ; Antihyperglycaemics; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 01 Sep 2012 Status changed from recruiting to completed based on results published in Diabetes, Obesity and Metabolism.
- 01 Sep 2012 Results published in the Diabetes, Obesity and Metabolism.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History